Fladby, Tormod
University of Oslo · Akershus University Hospital
24 papers on CoChatORCID 0000-0002-9984-9797
Most cited papers
- Verified
New insights into the genetic etiology of Alzheimer’s disease and related dementias
Bellenguez, C., Küçükali, F., Jansen, I. E., Kleineidam, L., Moreno-Grau, S., Amin, N., Naj, A. C., Campos-Martin, R., Grenier-Boley, B., Andrade, V., et al. (2022) · Nature Genetics
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 2,498
- Verified
Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk
Jansen, I. E., Savage, J. E., Watanabe, K., Bryois, J., Williams, D. M., Steinberg, S., Sealock, J., Karlsson, I. K., Hägg, S., Athanasiu, L., et al. (2019) · Nature Genetics
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 2,277
- Verified
Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease
Fang, E. F., Hou, Y., Palikaras, K., Adriaanse, B. A., Kerr, J. S., Yang, B., Lautrup, S., Hasan-Olive, M. M., Caponio, D., Dan, X., et al. (2019) · Nature Neuroscience
Alzheimer's disease research and treatmentsAutophagy in Disease and Therapy
Cited by 1,740
- Verified
Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia: A Meta-analysis
Jansen, W. J., Ossenkoppele, R., Knol, D. L., Tijms, B. M., Scheltens, P., Verhey, F. R. J., Visser, P. J., Aalten, P., Aarsland, D., Alcolea, D., et al. (2015) · JAMA
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 1,610
- Verified
A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer’s disease
Wightman, D. P., Jansen, I. E., Savage, J. E., Shadrin, A. A., Bahrami, S., Holland, D., Rongve, A., Børte, S., Winsvold, B. S., Drange, O. K., et al. (2021) · Nature Genetics
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 1,011
- Verified
A practical guide to immunoassay method validation
Andreasson, U., Perret-Liaudet, A., van Waalwijk van Doorn, L. J. C., Blennow, K., Chiasserini, D., Engelborghs, S., Fladby, T., Genc, S., Kruse, N., Kuiperij, H. B., et al. (2015) · Frontiers in Neurology
Clinical Laboratory Practices and Quality ControlAdvanced Biosensing Techniques and Applications
Cited by 546
- Verified
Loss-of-function variants in ABCA7 confer risk of Alzheimer's disease
DemGene, Steinberg, S., Stefansson, H., Jonsson, T., Johannsdottir, H., Ingason, A., Helgason, H., Sulem, P., Magnusson, O. T., Gudjonsson, S. A., et al. (2015) · Nature Genetics
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 324
- Verified
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum
Jansen, W. J., Janssen, O., Tijms, B. M., Vos, S. J. B., Ossenkoppele, R., Visser, P. J., Amyloid Biomarker Study Group, Aarsland, D., Alcolea, D., Altomare, D., et al. (2022) · JAMA Neurology
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 290
- Verified
Glial activation and inflammation along the Alzheimer’s disease continuum
Nordengen, K., Kirsebom, B.-E., Henjum, K., Selnes, P., Gísladóttir, B., Wettergreen, M., Torsetnes, S. B., Grøntvedt, G. R., Waterloo, K. K., Aarsland, D., et al. (2019) · Journal of Neuroinflammation
Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments
Cited by 274
- Verified
Drug repositioning and repurposing for Alzheimer disease
Ballard, C., Aarsland, D., Cummings, J., O’Brien, J., Mills, R., Molinuevo, J. L., Fladby, T., Williams, G., Doherty, P., Corbett, A., et al. (2020) · Nature Reviews Neurology
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 201
- Verified
Polygenic Overlap Between C-Reactive Protein, Plasma Lipids, and Alzheimer Disease
Desikan, R. S., Schork, A. J., Wang, Y., Thompson, W. K., Dehghan, A., Ridker, P. M., Chasman, D. I., McEvoy, L. K., Holland, D., Chen, C.-H., et al. (2015) · Circulation
Alzheimer's disease research and treatmentsGenetic Associations and Epidemiology
Cited by 154
- Verified
EFNS ‐ ENS / EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease
Schmidt, R., Hofer, E., Bouwman, F. H., Buerger, K., Cordonnier, C., Fladby, T., Galimberti, D., Georges, J., Heneka, M. T., Hort, J., et al. (2015) · European Journal of Neurology
Dementia and Cognitive Impairment ResearchCholinesterase and Neurodegenerative Diseases
Cited by 140
- Verified
Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers
Jansen, I. E., van der Lee, S. J., Gomez-Fonseca, D., de Rojas, I., Dalmasso, M. C., Grenier-Boley, B., Zettergren, A., Mishra, A., Ali, M., Andrade, V., et al. (2022) · Acta Neuropathologica
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 132
- Verified
Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease
Mattsson, N., Groot, C., Jansen, W. J., Landau, S. M., Villemagne, V. L., Engelborghs, S., Mintun, M. M., Lleo, A., Molinuevo, J. L., Jagust, W. J., et al. (2018) · Alzheimer's & Dementia
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 88
- Verified
Association of Copy Number Variation of the 15q11.2 BP1-BP2 Region With Cortical and Subcortical Morphology and Cognition
Writing Committee for the ENIGMA-CNV Working Group, van der Meer, D., Sønderby, I. E., Kaufmann, T., Walters, G. B., Abdellaoui, A., Ames, D., Amunts, K., Andersson, M., Armstrong, N. J., et al. (2020) · JAMA Psychiatry
Genomic variations and chromosomal abnormalitiesGenetics and Neurodevelopmental Disorders
Cited by 87
- Verified
Genome-wide analysis of attention deficit hyperactivity disorder in Norway
Zayats, T., Athanasiu, L., Sonderby, I., Djurovic, S., Westlye, L. T., Tamnes, C. K., Fladby, T., Aase, H., Zeiner, P., Reichborn-Kjennerud, T., et al. (2015) · PLoS ONE
Attention Deficit Hyperactivity DisorderGenetic Associations and Epidemiology
Cited by 83
- Verified
Brain amyloid and vascular risk are related to distinct white matter hyperintensity patterns
Pålhaugen, L., Sudre, C. H., Tecelao, S., Nakling, A., Almdahl, I. S., Kalheim, L. F., Cardoso, M. J., Johnsen, S. H., Rongve, A., Aarsland, D., et al. (2021) · Journal of Cerebral Blood Flow & Metabolism
Cerebrovascular and genetic disordersDementia and Cognitive Impairment Research
Cited by 79
- Verified
Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis
Mattsson, N., Axelsson, M., Haghighi, S., Malmeström, C., Wu, G., Anckarsäter, R., Sankaranarayanan, S., Andreasson, U., Fredrikson, S., Gundersen, A., et al. (2009) · Multiple Sclerosis Journal
Multiple Sclerosis Research StudiesAlzheimer's disease research and treatments
Cited by 61
- Verified
Altered DNA base excision repair profile in brain tissue and blood in Alzheimer’s disease
Lillenes, M. S., Rabano, A., Støen, M., Riaz, T., Misaghian, D., Møllersen, L., Esbensen, Y., Günther, C.-C., Selnes, P., Stenset, V. T. V., et al. (2016) · Molecular Brain
Alzheimer's disease research and treatmentsDNA Repair Mechanisms
Cited by 46
- Verified
Associations between white matter lesions, cerebrovascular risk factors, and low CSF Aβ42
Stenset, V., Johnsen, L., Kocot, D., Negaard, A., Skinningsrud, A., Gulbrandsen, P., Wallin, A., & Fladby, T. (2006) · Neurology
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 44
- Verified
Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study
Kruse, N., Persson, S., Alcolea, D., Bahl, J. M. C., Baldeiras, I., Capello, E., Chiasserini, D., Bocchio Chiavetto, L., Emersic, A., Engelborghs, S., et al. (2015) · Neurobiology of Aging
Parkinson's Disease Mechanisms and TreatmentsClinical Laboratory Practices and Quality Control
Cited by 38
- Verified
A randomised placebo-controlled study of purified anthocyanins on cognition in individuals at increased risk for dementia
Aarsland, D., Khalifa, K., Bergland, A. K., Soennesyn, H., Oppedal, K., Holteng, L. B. A., Oesterhus, R., Nakling, A., Jarholm, J. A., de Lucia, C., et al. (2023) · The American Journal of Geriatric Psychiatry
Dementia and Cognitive Impairment ResearchPhytochemicals and Antioxidant Activities
Cited by 36
- Verified
Consensus meta-analysis of genome-wide association studies for Alzheimer’s disease and related dementias
EADB, Bellenguez, C., Castillo Morales, A., Amin, N., van der Lee, S. J., Muntaner, M., Parveen, K., Küçükali, F., Grenier-Boley, B., Heikkinen, S., et al. (2026) · Nature Genetics
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 7
- Verified
Alzheimer’s disease genetics converges on microglial and neuronal dysregulation
Uffelmann, E., Wightman, D. P., Bahrami, S., Shadrin, A. A., Fominykh, V., Ojima, T., Jiang, C., Benner, C., Moreno, E., Campos, A. I., et al. (2026) · Nature
Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms
Cited by 0
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free